Name: Voyager Therapeutics, Inc. (VYGR) Balance Sheet
Creator: FinSpry

Voyager Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Voyager Therapeutics, Inc. (VYGR) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018
Current Assets
Cash and Cash Equivalents	71.37	68.80	98.96	117.43	181.14	281.53	155.81
Short-Term Investments	195.32	162.07	19.89	15.11	76.70	0.00	0.00
Cash & Short-Term Investments	266.68	230.88	118.85	132.54	181.14	281.53	155.81
Accounts Receivable	4.49	80.15	0.64	0.73	8.01	18.50	0.20
Inventory	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	0.43	2.63	0.70	1.70	1.58	1.40	1.36
Total Current Assets	276.81	319.68	124.50	136.70	197.77	304.66	162.48
Non-Current Assets
Property, Plant & Equipment (Net)	47.66	30.00	33.34	55.38	61.50	28.47	12.77
Long-Term Investments	65.70	0.00	0.00	0.00	0.00	0.00	0.00
Other Non-Current Assets	2.87	1.59	1.52	1.78	2.32	0.00	0.74
Total Non-Current Assets	116.24	31.60	34.86	57.16	63.82	32.12	14.55
Total Assets	393.05	351.28	159.36	193.86	261.58	354.76	177.03
Current Liabilities
Accounts Payable	4.00	1.60	2.57	0.57	14.84	25.59	7.05
Short-Term Debt	7.23	0.00	0.00	0.00	0.00	0.00	0.00
Accrued Liabilities	14.17	10.21	7.82	5.93	14.21	0.00	0.00
Deferred Revenue	24.39	42.88	59.38	33.89	7.73	0.00	0.00
Other Current Liabilities	14.17	6.61	2.83	5.57	4.20	3.19	0.00
Total Current Liabilities	49.79	64.51	72.59	50.98	26.77	76.01	31.67
Non-Current Liabilities
Long-Term Debt	36.50	17.09	20.29	38.61	0.00	0.00	0.00
Other Non-Current Liabilities	1.00	1.00	1.00	1.00	44.41	31.98	1.00
Total Non-Current Liabilities	43.50	50.45	27.75	47.82	80.50	179.24	98.91
Total Liabilities	93.29	114.96	100.34	98.80	107.26	255.25	130.58
Stockholders' Equity
Common Stock	0.06	0.04	0.04	0.04	0.04	0.00	0.00
Retained Earnings	-326.18	-261.18	-393.51	-347.10	-276.04	-312.65	-269.05
Accumulated Other Comprehensive Income	-0.41	-0.05	-0.22	-0.14	-0.13	-0.10	-0.13
Additional Paid-in Capital	626.30	497.51	452.71	442.26	430.32	412.23	315.60
Shares Outstanding	54.73	44.04	38.61	37.92	0.00	0.00	0.00
Total Stockholders' Equity	299.76	236.32	59.02	95.06	154.32	99.51	46.45
Total Liabilities & Equity	393.05	351.28	159.36	193.86	261.58	354.76	177.03